N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detectionin acute myeloid leukemia. - Coustan-Smith,E.; Brehm,F.G.; Hurwitz,C.A.; Rivera,G.K.; Campana,D. (Leukemia, 1993)